| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 8888888 |
Internal/system code - not a standard HCPCS code |
15,888 |
5,038 |
$4.40M |
| 36415 |
Collection of venous blood by venipuncture |
5,790 |
4,519 |
$747K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
609 |
550 |
$116K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
2,257 |
2,103 |
$73K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,527 |
2,286 |
$38K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,540 |
2,151 |
$28K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,434 |
2,111 |
$25K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
586 |
550 |
$25K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,358 |
1,179 |
$17K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
170 |
159 |
$17K |
| 81003 |
|
1,000 |
910 |
$10K |
| 87400 |
|
139 |
136 |
$9K |
| 71045 |
Radiologic examination, chest; single view |
610 |
566 |
$9K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
164 |
155 |
$9K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,912 |
1,578 |
$8K |
| 70450 |
Computed tomography, head or brain; without contrast material |
243 |
225 |
$8K |
| 81001 |
|
1,532 |
1,365 |
$7K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,813 |
3,143 |
$7K |
| 80053 |
Comprehensive metabolic panel |
3,573 |
3,005 |
$7K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
156 |
149 |
$5K |
| 71046 |
Radiologic examination, chest; 2 views |
154 |
139 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
82 |
71 |
$5K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
88 |
82 |
$5K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
341 |
312 |
$4K |
| 87631 |
|
25 |
24 |
$4K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,334 |
1,110 |
$3K |
| 83690 |
|
1,001 |
857 |
$2K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
57 |
36 |
$2K |
| 84703 |
|
1,207 |
1,083 |
$2K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
359 |
316 |
$2K |
| 86710 |
|
15 |
15 |
$2K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,161 |
1,025 |
$1K |
| 84484 |
|
667 |
466 |
$1K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
14 |
13 |
$1K |
| 81025 |
|
99 |
86 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,188 |
1,661 |
$1K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
890 |
573 |
$887.89 |
| 80050 |
General health panel |
375 |
353 |
$885.81 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
42 |
40 |
$699.46 |
| 82077 |
|
187 |
170 |
$548.05 |
| 59025 |
Fetal non-stress test |
17 |
12 |
$507.21 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12 |
12 |
$428.80 |
| 87088 |
|
42 |
39 |
$335.47 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
612 |
553 |
$278.84 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,533 |
1,159 |
$188.36 |
| 94761 |
|
80 |
51 |
$186.40 |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
13 |
12 |
$102.81 |
| 85379 |
|
72 |
68 |
$26.97 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
54 |
52 |
$25.00 |
| 96376 |
|
249 |
216 |
$16.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
43 |
34 |
$15.88 |
| 80179 |
|
98 |
89 |
$14.91 |
| 80143 |
|
130 |
114 |
$14.91 |
| J2060 |
Injection, lorazepam, 2 mg |
117 |
84 |
$10.42 |
| 85610 |
|
13 |
12 |
$2.51 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
308 |
238 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
284 |
204 |
$0.00 |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
20 |
17 |
$0.00 |
| 84439 |
|
14 |
14 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
43 |
37 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
400 |
299 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
409 |
194 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
22 |
15 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
473 |
275 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
376 |
262 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
81 |
72 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
350 |
266 |
$0.00 |
| 86140 |
|
13 |
13 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
77 |
52 |
$0.00 |
| 87081 |
|
13 |
13 |
$0.00 |
| 80320 |
|
13 |
13 |
$0.00 |
| A9270 |
Non-covered item or service |
50 |
12 |
$0.00 |
| 83880 |
|
13 |
12 |
$0.00 |
| 85027 |
|
13 |
13 |
$0.00 |